A Modularized Stretchable Microneedle Array for Minimally Invasive and Efficient Drug Delivery

preprint OA: closed
Full text JSON View at publisher

Abstract

ABSTRACT A novel Modularized Stretchable Microneedle Array (MSMA) is developed for minimally invasive and efficient drug delivery. By applying a modular design, the MSMA can be highly customized, offering versatility for different therapeutic applications. Its high stretchability allows for simultaneous stretching of both the microneedle and the skin, enhancing the penetration rate. Evaluations using tissue-mimicking materials and porcine skin demonstrated significant improvements in penetration efficiency and reduced residual strain. The MSMA achieved penetration rates of up to 89% on porcine skin under a minimum push-down distance of 2 mm. Moreover, the MSMA’s ability to stretch and release in synchronization with the skin significantly reduces residual strain. This innovative platform promises reduced pain and discomfort, representing a substantial advancement in transdermal drug delivery technology.
Full text 994 characters · extracted from oa-doi-fallback · click to expand
ABSTRACT A novel Modularized Stretchable Microneedle Array (MSMA) is developed for minimally invasive and efficient drug delivery. By applying a modular design, the MSMA can be highly customized, offering versatility for different therapeutic applications. Its high stretchability allows for simultaneous stretching of both the microneedle and the skin, enhancing the penetration rate. Evaluations using tissue-mimicking materials and porcine skin demonstrated significant improvements in penetration efficiency and reduced residual strain. The MSMA achieved penetration rates of up to 89% on porcine skin under a minimum push-down distance of 2 mm. Moreover, the MSMA’s ability to stretch and release in synchronization with the skin significantly reduces residual strain. This innovative platform promises reduced pain and discomfort, representing a substantial advancement in transdermal drug delivery technology. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00